BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,747,068 | -16.8% | 6,193,616 | +0.4% | 0.04% | -16.7% |
| Q2 2023 | $280,995,401 | +9.0% | 6,167,590 | -2.9% | 0.05% | +5.9% |
| Q1 2023 | $257,728,866 | -19.5% | 6,354,262 | +1.2% | 0.05% | -23.9% |
| Q4 2022 | $319,993,380 | -2.4% | 6,278,073 | +3.2% | 0.07% | -10.7% |
| Q3 2022 | $327,772,000 | -16.8% | 6,085,628 | -0.7% | 0.08% | -10.7% |
| Q2 2022 | $393,830,000 | -19.5% | 6,131,563 | -2.8% | 0.08% | -2.3% |
| Q1 2022 | $489,057,000 | -11.1% | 6,307,158 | -1.6% | 0.09% | -4.4% |
| Q4 2021 | $550,228,000 | +7.2% | 6,409,938 | +0.5% | 0.09% | -1.1% |
| Q3 2021 | $513,092,000 | -14.3% | 6,379,371 | -14.2% | 0.09% | -13.3% |
| Q2 2021 | $598,721,000 | -7.6% | 7,437,528 | -3.2% | 0.10% | -13.2% |
| Q1 2021 | $648,174,000 | +3.0% | 7,685,245 | -2.0% | 0.12% | -1.6% |
| Q4 2020 | $629,374,000 | -4.2% | 7,843,648 | -4.0% | 0.12% | -14.6% |
| Q3 2020 | $656,888,000 | -10.2% | 8,168,239 | -3.9% | 0.14% | -16.8% |
| Q2 2020 | $731,486,000 | +6.6% | 8,495,772 | +0.5% | 0.17% | -12.2% |
| Q1 2020 | $686,318,000 | -5.4% | 8,453,226 | -2.5% | 0.20% | +21.6% |
| Q4 2019 | $725,251,000 | -4.5% | 8,673,186 | -0.1% | 0.16% | -11.0% |
| Q3 2019 | $759,736,000 | +5.9% | 8,685,672 | -0.8% | 0.18% | +7.1% |
| Q2 2019 | $717,323,000 | +1.4% | 8,758,537 | +0.6% | 0.17% | -2.9% |
| Q1 2019 | $707,694,000 | +24.8% | 8,703,648 | +1.0% | 0.18% | +10.1% |
| Q4 2018 | $567,073,000 | -13.2% | 8,615,513 | +1.6% | 0.16% | -0.6% |
| Q3 2018 | $653,648,000 | +3.2% | 8,479,037 | -1.2% | 0.16% | -0.6% |
| Q2 2018 | $633,579,000 | +9.2% | 8,580,420 | -3.8% | 0.16% | +6.6% |
| Q1 2018 | $580,324,000 | -3.4% | 8,922,567 | -4.0% | 0.15% | -0.7% |
| Q4 2017 | $600,777,000 | +3.4% | 9,294,206 | +0.4% | 0.15% | +0.7% |
| Q3 2017 | $580,947,000 | +6.8% | 9,258,111 | +3.1% | 0.15% | -0.7% |
| Q2 2017 | $543,806,000 | +26.8% | 8,982,585 | +8.6% | 0.15% | +22.6% |
| Q1 2017 | $428,851,000 | +19.6% | 8,269,414 | +2.3% | 0.12% | +12.7% |
| Q4 2016 | $358,577,000 | -15.0% | 8,087,001 | -8.8% | 0.11% | -16.0% |
| Q3 2016 | $421,972,000 | +1.9% | 8,864,966 | -3.2% | 0.13% | -2.2% |
| Q2 2016 | $414,248,000 | +10.7% | 9,160,737 | -0.5% | 0.13% | +8.1% |
| Q1 2016 | $374,111,000 | +7.8% | 9,206,984 | +1.2% | 0.12% | +7.8% |
| Q4 2015 | $347,023,000 | +9.1% | 9,096,270 | -6.0% | 0.12% | +8.5% |
| Q3 2015 | $318,016,000 | -52.4% | 9,680,850 | +1.3% | 0.11% | -47.3% |
| Q2 2015 | $668,495,000 | -2.1% | 9,559,486 | -4.1% | 0.20% | -2.0% |
| Q1 2015 | $682,756,000 | -10.2% | 9,967,242 | -3.9% | 0.20% | -10.5% |
| Q4 2014 | $760,099,000 | +6.7% | 10,371,108 | +4.4% | 0.23% | +2.2% |
| Q3 2014 | $712,689,000 | -0.6% | 9,930,166 | +0.2% | 0.22% | +0.4% |
| Q2 2014 | $716,870,000 | -5.0% | 9,915,220 | -3.4% | 0.22% | -5.9% |
| Q1 2014 | $754,885,000 | +14.8% | 10,259,379 | +8.5% | 0.24% | +12.3% |
| Q4 2013 | $657,504,000 | +19.5% | 9,453,689 | +12.9% | 0.21% | +8.8% |
| Q3 2013 | $550,155,000 | -8.8% | 8,375,028 | -3.8% | 0.19% | -11.4% |
| Q2 2013 | $603,313,000 | – | 8,709,601 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |